InvestorsObserver

MRMD Marimed Inc

$0.26 $0.01 (2.00%)
15 Minute Delayed Price Enable Real-Time Price
Overall

MRMD Stock Analysis Overview

What this means: Marimed Inc (MRMD) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives MRMD a rank of 11. Our methodology considers analysis of the company's financial situation and how it has traded recently. MRMD rank of 11 means that it ranks below 89% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

View Sample Report
Fundamental PREMIUM

MRMD Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

Short-Term Technical PREMIUM

MRMD Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

Long-Term Technical PREMIUM

MRMD Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

Analyst Ranking PREMIUM

MRMD Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

Valuation PREMIUM

MRMD Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

Stock Sentiment PREMIUM

MRMD Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

MRMD Stock Analysis Overview

What this means: Marimed Inc (MRMD) gets a very poor rank from InvestorsObserver. Our comprehensive analysis of fundamental and technical factors gives MRMD a rank of 11. Our methodology considers analysis of the company's financial situation and how it has traded recently. MRMD rank of 11 means that it ranks below 89% of stocks.

Who this matters to: Overall Ranking is a comprehensive evaluation. It considers technical and fundamental factors and is a good starting point for evaluating a stock.

Create a FREE account to see full MRMD report

MRMD Fundamental Analysis

Who this matters to: The Fundamental Ranking considers the health of the underlying company. It is best used by longer-term buy-and-hold investors.

Upgrade to Premium to unlock Fundamental Ranking

MRMD Short-Term Technical Analysis

Who this matters to: The Short-Term Technical Ranking evaluates a stock’s trading over the past month. This is most useful for short- to medium-term stock and option traders.

Upgrade to Premium to unlock Short-Term Technical Ranking

MRMD Long-Term Technical Analysis

Who this matters to: The Long-Term Technical Ranking is a good gauge of how a stock has traded over the past several months. This is useful for medium to long-term stock and option traders.

Upgrade to Premium to unlock Long-Term Technical Ranking

MRMD Analyst Ranking

Who this matters to: Analyst Ranking shows you which stocks Wall Street analysts like the most. Since analysts build valuation models, this is most useful for medium to long-term investors who are interested in a valuation-based approach.

Upgrade to Premium to unlock Analyst Ranking Analysis

MRMD Valuation Ranking Analysis

Who this matters to: Valuation Ranking is most-useful for value-focused investors who plan to hold a stock for the long term.

Upgrade to Premium to unlock Valuation Ranking

MRMD Stock Sentiment Analysis

Who this matters to: Sentiment Rank looks at the past five trading days. This is our shortest-term evaluation and is best used by people with a very short horizon.

Upgrade to Premium to unlock Stock Sentiment Ranking

Marimed Inc (MRMD) Analyst Forecast

MRMD Price, Volume, Earnings, and Dividend Date

  • Last Price $0.26
  • Previous Close $0.25
  • Change $0.01
  • Open $0.26
  • Volume 171,737
  • Avg. Volume (100-day) 428,572
  • Market Cap 95,658,141
  • Days Range 0.255 - 0.2699
  • 52-week Range 0.2 - 0.55
  • Dividend Yield
  • Ex. Dividend Date
  • P-E
  • EPS
  • Earnings Date
  • Sector Healthcare
  • Industry Biotechnology
  • Avg. Analyst Rec. Premium
  • Beta 0.763
  • PEG Ratio

Marimed Inc (MRMD) Company Description

MariMed Inc offers turnkey solutions to cannabis cultivators, producers, and dispensaries. It advises its clients in securing cannabis licenses, and in turn, develops and manages, regulatory-compliant facilities for the cultivation, production, and dispensary of legal cannabis. The company also has created a brand of precision-dosed cannabis-infused products, under the brand name Kalm Fusion which are licensed and distributed nationally. It has approximately five active and fully operational facilities in Delaware, Illinois, and Nevada and three facilities under stages of acquisition in Maryland. It has two segments online portal operations and cannabis operations. Maximum revenue is generated from cannabis segment.

Marimed Inc (MRMD) Stock Chart